Skip to content
ePORE Therapy Logo
  • Platform
    • ePORE® therapy Technology
    • ePORE® therapy Treats
    • Benefits of ePORE® therapy
    • EndoVE®
    • CUTIS
  • Gastrointestinal Therapy
    • Clinicians
    • Patient Information
  • Skin Therapy
    • Clinicians
    • Patient Information
  • News
  • About Mirai
  • Contact
  • Platform
    • ePORE® therapy Technology
    • ePORE® therapy Treats
    • Benefits of ePORE® therapy
    • EndoVE®
    • CUTIS
  • Gastrointestinal Therapy
    • Clinicians
    • Patient Information
  • Skin Therapy
    • Clinicians
    • Patient Information
  • News
  • About Mirai
  • Contact

Category: White Papers

Filter by Topic
Filter by Topic
The first clinical paper published using electroporation in conjunction with calcium for the treatment of colorectal cancer
Read More
13.02.2023
Endoscopic electrochemotherapy for Oesophageal cancer: a phase I clinical study
Read More
25.03.2021
Phase one Study on electrochemotherapy for colorectal cancer using endoscopic electroporation
Read More
25.03.2021

Contact Us

By clicking send, you confirm you have read and agreed to Mirai Medical's Privacy Policy.
Twitter Linkedin-in Youtube
ePORE Therapy White Logo
Address:
Mirai Medical
Unit 5, Howley Court
Oranmore
Galway
Ireland
Email:
info@mirai-medical.com
Mirai Medical logo white
© Copyright 2025 MIRAI MEDICAL. All Rights Reserved.
Privacy & Cookies
ePORE® therapy, EndoVE® and CUTIS are approved for commercialisation in the European Union, United Kingdom and Australia. ePORE® therapy, EndoVE® and CUTIS are not cleared by FDA for commercialisation in the USA.
WEEE Ireland Certificate of Registration MIR 100
PRL Registration Number: IE 02581 WB
Website by Proactive Design & Marketing